Invesco Ltd.

Position in ALXO — Alx Oncology Holdings Inc

CIK 914208 Atlanta, GA

Position in ALXO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$310,338

+$288,324 QoQ

Shares Held

149,923

+1265.4% QoQ

Ownership

0.108%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 94 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 0% Shared 98% None 2%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. ALXO ranks #217 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$310,338	149,923	+1265.4%	Shares	Defined	2026-08-14
2026-03-31	$22,014	10,980	-85.1%	Shares	Defined	2026-05-12
2025-03-31	$45,998	73,836	+617.6%	Shares	Defined	2025-05-12
2024-06-30	$62,048	10,290	-97.3%	Shares	Defined	2024-08-13
2023-12-31	$5,736,103	385,232	-40.1%	Shares	Defined	2024-02-13
2022-03-31	$10,874,929	643,487	+2.2%	Shares	Defined	2022-05-16
2021-12-31	$13,537,022	629,922	+22.4%	Shares	Defined	2022-02-14
2021-09-30	$38,024,233	514,815	+6841.9%	Shares	Defined	2021-11-15
2021-06-30	$405,505	7,416	+132.4%	Shares	Defined	2021-08-17
2021-03-31	$235,303	3,191	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.